Takuya Tsujino

Osaka University of Pharmaceutical Sciences

Papers

1

Total Citations

3

H-Index

1

About

Dr. Takuya Tsujino is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for kidney cancer, with a particular focus on robot-assisted partial nephrectomy (RAPN). His major contributions lie in demonstrating the safety and efficacy of RAPN for the most challenging cases, specifically renal hilar tumors—tumors located near the kidney's critical blood vessels. Dr. Tsujino spearheaded the landmark ROBOHIT trial, a prospective, multi-institutional study across 22 academic hospitals in Japan, which provided crucial long-term follow-up data on both oncological control and functional kidney preservation. This work, published in 2025, has already garnered 3 citations, underscoring its immediate relevance to the field. By systematically evaluating outcomes for these complex tumors, Dr. Tsujino has helped establish best practices and expand the indications for robotic surgery, offering patients a less invasive option with promising results. His research is instrumental in shaping modern urologic oncology, providing surgeons with the evidence needed to confidently approach technically demanding procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( <scp>ROBOHIT</scp> Trial)
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago